Overview of Dr. Politikos
Dr. Ioannis Politikos is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from University of Athens and has been in practice 11 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 50 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Mount Auburn HospitalResidency, Internal Medicine, 2009 - 2012
University of AthensClass of 2006
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2017 - 2026
CT State Medical License 2023 - 2025
NJ State Medical License 2018 - 2025
MA State Medical License 2009 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation Start of enrollment: 2018 Feb 07
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 6 citationsRacial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation.Warren B Fingrut, Eric Davis, Anne Archer, Samantha Brown, Sean Devlin
Blood Advances. 2024-06-11 - 2 citationsGender disparities in allograft access due to HLA-sensitization in multiparous women.Warren B Fingrut, Eric Davis, Anne Archer, Samantha Brown, Sean Devlin
Blood Advances. 2024-01-23 - 4 citationsOutcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.Maria-Stefania Infante, David Nemirovsky, Sean Devlin, Susan DeWolf, Roni Tamari
Transplantation and Cellular Therapy. 2024-01-01
Abstracts/Posters
- Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T CellsIoannis Politikos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell TransplantationIoannis Politikos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Relapse Risk Lower with Double CBT Than with Matched Sibling or Unrelated TransplantMay 5th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
